Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors

Haematol Blood Transfus. 1987:30:466-70. doi: 10.1007/978-3-642-71213-5_82.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Belgien
  • Child
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Doxorubicin / administration & dosage
  • Frankreich
  • Humans
  • Leukemia, Lymphoid / drug therapy*
  • Methotrexate / administration & dosage
  • Prednisone / administration & dosage
  • Prognosis
  • Remission Induction
  • Risk
  • Thioguanine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Asparaginase
  • Thioguanine
  • Prednisone
  • Methotrexate

Supplementary concepts

  • BFM 78 protocol